Centric Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $770K | Hold |
29,277
| – | – | 0.12% | 109 |
|
|
2026
Q1 | $770K | Buy |
29,277
+97
| +0.3% | +$2.58K | 0.15% | 102 |
|
|
2025
Q4 | $778K | Sell |
29,180
-1,686
| -5% | -$42.5K | 0.16% | 103 |
|
|
2025
Q3 | $761K | Sell |
30,866
-90,514
| -75% | -$2.23M | 0.17% | 99 |
|
|
2025
Q2 | $2.98M | Buy |
121,380
+15,219
| +14% | +$355K | 0.71% | 49 |
|
|
2025
Q1 | $2.69M | Buy |
106,161
+20,164
| +23% | +$528K | 0.71% | 50 |
|
|
2024
Q4 | $2.28M | Buy |
85,997
+54,736
| +175% | +$1.48M | 0.62% | 50 |
|
|
2024
Q3 | $855K | Sell |
31,261
-13
| -0% | -$379 | 0.23% | 89 |
|
|
2024
Q2 | $962K | Sell |
31,274
-51,842
| -62% | -$1.43M | 0.28% | 69 |
|
|
2024
Q1 | $2.13M | Sell |
83,116
-727
| -0.9% | -$20.2K | 0.68% | 44 |
|
|
2023
Q4 | $2.23M | Buy |
83,843
+11,849
| +16% | +$358K | 0.73% | 38 |
|
|
2023
Q3 | $2.39M | Buy |
71,994
+1,101
| +2% | +$38.9K | 1% | 26 |
|
|
2023
Q2 | $2.53M | Buy |
70,893
+55,796
| +370% | +$2.17M | 1.01% | 24 |
|
|
2023
Q1 | $616K | Sell |
15,097
-28
| -0.2% | -$1.21K | 0.27% | 64 |
|
|
2022
Q4 | $775K | Sell |
15,125
-3,309
| -18% | -$159K | 0.39% | 56 |
|
|
2022
Q3 | $807K | Sell |
18,434
-550
| -3% | -$26.7K | 0.32% | 74 |
|
|
2022
Q2 | $995K | Sell |
18,984
-610
| -3% | -$31.1K | 0.37% | 76 |
|
|
2022
Q1 | $1.01M | Buy |
19,594
+333
| +2% | +$17.3K | 0.32% | 79 |
|
|
2021
Q4 | $1.14M | Buy |
19,261
+58
| +0.3% | +$2.87K | 0.37% | 69 |
|
|
2021
Q3 | $826K | Buy |
19,203
+45
| +0.2% | +$1.99K | 0.3% | 76 |
|
|
2021
Q2 | $750K | Sell |
19,158
-59,029
| -75% | -$2.3M | 0.26% | 84 |
|
|
2021
Q1 | $2.83M | Buy |
78,187
+38,745
| +98% | +$1.38M | 0.81% | 23 |
|
|
2020
Q4 | $1.45M | Buy |
39,442
+3,794
| +11% | +$139K | 0.45% | 59 |
|
|
2020
Q3 | $1.17M | Buy |
+35,648
| New | +$1.25M | 0.88% | 27 |
|
|
2020
Q2 | – | Sell |
-35,648
| Closed | -$1.17M | – | 154 |
|
|
2020
Q1 | $1.17M | Sell |
35,648
-1,803
| -5% | -$61.4K | 0.88% | 27 |
|
|
2019
Q4 | $1.39M | Buy |
37,451
+1,803
| +5% | +$64.2K | 1.11% | 20 |
|
|
2019
Q3 | $1.17M | Buy |
35,648
+8,583
| +32% | +$312K | 0.88% | 27 |
|
|
2019
Q2 | $1.11M | Buy |
27,065
+182
| +0.7% | +$7.23K | 0.97% | 26 |
|
|
2019
Q1 | $1.08M | Buy |
26,883
+49
| +0.2% | +$1.96K | 1% | 24 |
|
|
2018
Q4 | $1.11M | Buy |
+26,834
| New | +$1.11M | 0.98% | 19 |
|
Other funds holding PFE
Centric Wealth Management's PFE Position: Q2 2026 in Review
Centric Wealth Management held its Pfizer (PFE) position steady in Q2 2026 at 29,277 shares worth $770K. The position accounts for 0.12% of the portfolio, ranked #109.
Centric Wealth Management first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.98M in Q2 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Centric Wealth Management held 29,277 shares of Pfizer worth $770K as of Q2 2026.
- Centric Wealth Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.12% of Centric Wealth Management's portfolio in Q2 2026, its #109 holding.
- Centric Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
- Centric Wealth Management's Pfizer position peaked at $2.98M in Q2 2025.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.